Recall Register

Drug recall: Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection, Rx Only, Compounded by: Innoveix Addison, TX 75001…

Class II FDA enforcement event 84006. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Lack of Sterility Assurance.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Innoveix Pharmaceuticals Inc started this drug recall on 10 Oct 2019. The firm address in the FDA record is in Addison, TX. FDA put the recall in Class II. FDA event 84006 has 4 product records. The first FDA enforcement report date is 6 Nov 2019. The record gives the status Terminated, with the termination date 14 Jan 2022. 56 of the 362 drug events that started in 2019 have more product records. The median drug event of 2019 has 1 product record. The openFDA file has 362 drug events that started in 2019 and 367 that started in 2018.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide within the United States

Recalling firm

Innoveix Pharmaceuticals Inc, Addison, TX.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

4 product records in the event.

FDA event 84006: product records
Recall numberProductQuantityClassStatusReport date
D-0157-2020Lyophilized Chorionic Gonadotropin 11,000 USP Units for Injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-19103905 vialsClass IITerminated6 Nov 2019
D-0158-2020Lyophilized Human Chorionic Gonadotropin 5,000 USP Units For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910413 vialsClass IITerminated6 Nov 2019
D-0159-2020Lyophilized Sermorelin w/ GHRP2 3 mg For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-19101747 vialsClass IITerminated6 Nov 2019
D-0160-2020Lyophilized Human Chorionic Gonadotropin 5,500 USP Units For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910290 vialsClass IITerminated6 Nov 2019

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2019
362
Share of these events in Class II
68%
Product records in this event
4Median of the firm: 4
Events of the firm on the register
2

Other events of the firm

Other FDA enforcement events of Innoveix Pharmaceuticals Inc
InitiatedProduct (first record)TypeClassRecords
9 Jul 2021Compounded Lyophilized Semorelin/Ipamorelin 3 mg For subcutaneous or intramuscular injection, Rx Only, Compounded by: InDrugClass II2

Official channels

Cite this page

Recall Register. FDA enforcement event 84006. https://recallregister.com/fda/ii/84006/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide within the United States
What quantity of product is in FDA event 84006?
The event has 4 product records. The first record gives this quantity: 3905 vials
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2019 have the same class?
68% of the 362 drug events that started in 2019 are in Class II.